Related Experiment Video
Updated: Jun 6, 2026
09:48
Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
A gene expression signature for insulin resistance
Nicky Konstantopoulos1, Victoria C Foletta, David H Segal
1Metabolic Research Unit, School of Medicine, Deakin University, Geelong, Australia. nicky.konstantopoulos@deakin.edu.au
Physiological Genomics
|November 18, 2010
Summary
Researchers developed a gene expression signature (GES) to identify insulin resistance. This signature aids in discovering new insulin-sensitizing drugs and personalizing type 2 diabetes treatments.
Area of Science:
- Metabolic disorders
- Genomics
- Pharmacology
Background:
- Insulin resistance is a complex, heterogeneous condition challenging type 2 diabetes management.
- Individual variations in etiology necessitate personalized therapeutic strategies.
Purpose of the Study:
- To develop a novel gene expression signature (GES) for assessing insulin resistance.
- To utilize the GES for discovering insulin-sensitizing compounds and patient stratification.
Main Methods:
- Gene expression profiling of 3T3-L1 adipocytes to create a GES.
- Screening a compound library using the GES to identify potential therapeutics.
- Validating the GES in a human cohort (San Antonio Family Heart Study).
Main Results:
- A five-gene GES was identified, distinguishing insulin-resistant from insulin-sensitized states.
- The GES screen identified known and novel insulin-sensitizing compounds.
- Lower GES scores correlated with higher insulin resistance in study participants.
Conclusions:
- The GES technology offers a novel approach for drug discovery in insulin resistance.
- GES can stratify patients, enabling personalized medicine for type 2 diabetes.
- This strategy holds promise for improved long-term management of type 2 diabetes.
Related Concept Videos
01:58Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...